Intriguingly, the high expression of PERK in breast cancer displayed an opposite prognosis with longer RFS (p = 0.044) and shorter DMFS (p = 0.022, Figure 3) in the absence of OS data. The gene discussed is EIF2AK3; the disease is breast carcinoma.